Fig. 5
From: Spatially fractionated GRID radiation potentiates immune-mediated tumor control
WTRT leads to clearance when Tx is sufficiently immunogenic. Parameter set 13: A Cancer-effector plane dynamics of mIHC slides 12, 28, 63, 93 treated with 2 Gy × 35 WTRT. B Snapshots of mIHC slides 12, 28, 63, 93 at the end of the first week of treatment (top row) and at the end of simulation (bottom row). Parameter set 15: C Cancer-effector plane dynamics of mIHC slides 12, 28, 63, 93 treated with 2 Gy × 35 WTRT. D Snapshots of mIHC slides 12, 28, 63, 93 at the end of the first week of treatment (top row) and at the end of simulation (bottom row)